(IEP) Icahn Enterprises - Overview
Stock: Investment, Energy, Automotive, Packaging, Pharma
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 23.22% |
| Yield on Cost 5y | 8.24% |
| Yield CAGR 5y | -29.29% |
| Payout Consistency | 58.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 35.2% |
| Relative Tail Risk | -16.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.10 |
| Alpha | -12.11 |
| Character TTM | |
|---|---|
| Beta | 0.744 |
| Beta Downside | 0.716 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.55% |
| CAGR/Max DD | -0.45 |
Description: IEP Icahn Enterprises January 10, 2026
Icahn Enterprises L.P. (NASDAQ:IEP) is a diversified holding company that operates through seven primary segments-Investment, Energy, Automotive, Food Packaging, Real Estate, Home Fashion, and Pharma-both in the United States and internationally. The firm was incorporated in 1987 and is headquartered in Sunny Isles Beach, Florida.
The Investment segment deploys proprietary capital into private funds and provides related advisory and back-office services. The Energy segment covers petroleum refining and marketing, renewable diesel production from feedstocks such as soybean and corn oil, and nitrogen fertilizer manufacturing (urea, ammonium nitrate, ammonia). The Automotive segment offers repair, maintenance, and aftermarket parts sales. Food Packaging produces cellulosic and plastic casings for processed meats. Real Estate holds a portfolio of land, retail, office, industrial properties, single-family home development, a resort, and two country clubs. Home Fashion manufactures and distributes consumer home goods, while the Pharma segment supplies approved therapies and develops pipeline products.
Recent data (Q4 2023) shows the Energy segment contributed roughly 45% of total revenue, with renewable diesel margins expanding 12% year-over-year as diesel demand rebounds and ESG mandates tighten. The Investment segment’s fee-related earnings rose 8% on higher AUM, reflecting strong fundraising in private equity. Macro-level, U.S. diesel price volatility and fertilizer demand linked to global grain production are key drivers of IEP’s earnings volatility.
For a deeper, data-driven view of IEP’s valuation dynamics, you might find ValueRay’s analytical tools useful.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -385.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA -2.36 > 1.0 |
| NWC/Revenue: 50.71% < 20% (prev 53.24%; Δ -2.53% < -1%) |
| CFO/TA 0.02 > 3% & CFO 352.0m > Net Income -385.0m |
| Net Debt (5.05b) to EBITDA (550.0m): 9.19 < 3 |
| Current Ratio: 3.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (575.0m) vs 12m ago 20.55% < -2% |
| Gross Margin: 10.09% > 18% (prev 0.11%; Δ 998.1% > 0.5%) |
| Asset Turnover: 60.36% > 50% (prev 60.45%; Δ -0.10% > 0%) |
| Interest Coverage Ratio: 0.03 > 6 (EBITDA TTM 550.0m / Interest Expense TTM 508.0m) |
Beneish M -3.26
| DSRI: 0.67 (Receivables 2.14b/3.45b, Revenue 9.74b/10.54b) |
| GMI: 1.12 (GM 10.09% / 11.34%) |
| AQI: 1.05 (AQ_t 0.24 / AQ_t-1 0.23) |
| SGI: 0.92 (Revenue 9.74b / 10.54b) |
| TATA: -0.05 (NI -385.0m - CFO 352.0m) / TA 14.83b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of IEP shares?
Over the past week, the price has changed by +3.08%, over one month by +2.95%, over three months by -7.04% and over the past year by +2.13%.
Is IEP a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IEP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12 | 49.6% |
| Analysts Target Price | 12 | 49.6% |
| ValueRay Target Price | 7.6 | -5% |
IEP Fundamental Data Overview February 03, 2026
P/S = 0.5044
P/B = 2.3916
Revenue TTM = 9.74b USD
EBIT TTM = 13.0m USD
EBITDA TTM = 550.0m USD
Long Term Debt = 6.67b USD (from longTermDebt, last quarter)
Short Term Debt = 1.43b USD (from shortTermDebt, last quarter)
Debt = 8.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.05b USD (from netDebt column, last quarter)
Enterprise Value = 9.25b USD (4.67b + Debt 8.61b - CCE 4.03b)
Interest Coverage Ratio = 0.03 (Ebit TTM 13.0m / Interest Expense TTM 508.0m)
EV/FCF = -1000.0x (Enterprise Value 9.25b / FCF TTM -2.00m)
FCF Yield = -0.02% (FCF TTM -2.00m / Enterprise Value 9.25b)
FCF Margin = -0.02% (FCF TTM -2.00m / Revenue TTM 9.74b)
Net Margin = -3.95% (Net Income TTM -385.0m / Revenue TTM 9.74b)
Gross Margin = 10.09% ((Revenue TTM 9.74b - Cost of Revenue TTM 8.76b) / Revenue TTM)
Gross Margin QoQ = 27.74% (prev 6.24%)
Tobins Q-Ratio = 0.62 (Enterprise Value 9.25b / Total Assets 14.83b)
Interest Expense / Debt = 1.42% (Interest Expense 122.0m / Debt 8.61b)
Taxrate = 23.61% (127.0m / 538.0m)
NOPAT = 9.93m (EBIT 13.0m * (1 - 23.61%))
Current Ratio = 3.33 (Total Current Assets 7.06b / Total Current Liabilities 2.12b)
Debt / Equity = 3.15 (Debt 8.61b / totalStockholderEquity, last quarter 2.73b)
Debt / EBITDA = 9.19 (Net Debt 5.05b / EBITDA 550.0m)
Debt / FCF = -2528 (out of range, set to none) (Net Debt 5.05b / FCF TTM -2.00m)
Total Stockholder Equity = 2.77b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.39% (Net Income -385.0m / Total Assets 14.83b)
RoE = -13.91% (Net Income TTM -385.0m / Total Stockholder Equity 2.77b)
RoCE = 0.14% (EBIT 13.0m / Capital Employed (Equity 2.77b + L.T.Debt 6.67b))
RoIC = 0.11% (NOPAT 9.93m / Invested Capital 8.73b)
WACC = 3.75% (E(4.67b)/V(13.28b) * Re(8.66%) + D(8.61b)/V(13.28b) * Rd(1.42%) * (1-Tc(0.24)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 18.14%
Fair Price DCF = unknown (Cash Flow -2.00m)
EPS Correlation: -3.19 | EPS CAGR: -19.78% | SUE: -0.29 | # QB: 0
Revenue Correlation: -67.96 | Revenue CAGR: 1.07% | SUE: 0.50 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.13 | Chg30d=+0.040 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.68 | Chg30d=+0.140 | Revisions Net=+1 | Growth EPS=+294.3% | Growth Revenue=-1.4%